SyneuRx SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing Posted on 2021-11-192021-12-09 by maxproadmin More >>
SyneuRx US FDA Approves SyneuRx’s IND Application for PhaseΠ Clinical Trial for Adult Patients with Treatment-Resistant Depression and Suicidal Symptoms Posted on 2021-03-262021-06-03 by maxproadmin More >>
SyneuRx TFDA Approves SyneuRx to Conduct Phasa Πb/Ш Clinical Trials for its Drug Candidates Treating Schizophrenia Posted on 2021-03-082021-06-03 by maxproadmin More >>
SyneuRx Ω-NaBen, the Ultimate and Supreme Sodium Benzoate Posted on 2021-02-262021-05-27 by maxproadmin More >>
SyneuRx First Five Subjects Randomized in SyneuRx’ SND12 PhaseIIb/III Study of Clozaben®, a Novel Traetment for Refractory Schizophrenia Posted on 2017-05-222021-02-07 by maxproadmin More >>
SyneuRx First Three Subjects Randomized in SyneuRx’s SND13 Phase IIb/III NaBen© Schizophrenia Trial Posted on 2017-05-112021-02-07 by maxproadmin More >>
SyneuRx FDA Approves SyneuRx’s IND Application for Late Phase Clinical Development of a Mild Dementia Treatment Posted on 2016-05-062021-02-07 by maxproadmin More >>
